Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2004 Sep 1;95(5):341–345. doi: 10.1007/BF03405142

Waiting Time for Breast Cancer Treatment in Alberta

Alyssa D Reed 14,✉, Robert J Williams 14, Patricia A Wall 14, Paul Hasselback 24
PMCID: PMC6975782  PMID: 15490922

Abstract

Background: The present study had two research questions. First, what is the average waiting time between diagnosis and treatment for Alberta women with breast cancer relative to Canadian Society for Surgical Oncology (CSSO) recommendations? Second, does patient age, cancer stage, patient community size, and year of diagnosis have a significant relationship to waiting time?

Methods: The sample consisted of all Alberta women diagnosed with breast cancer between 1997 and 2000. Waiting time was defined as number of days between definitive diagnosis and treatment initiation. Multiple regression examined the relative influence of the predictor variables on waiting time.

Results: There were 6,418 cases of breast cancer between 1997 and 2000. Mean waiting time was 20.2 days (SD 21.6) and median waiting time was 17 days. Longer waiting time was significantly associated with year of diagnosis (progressively longer from 1997 to 2000), patients younger than 70, and Stage 1 cancer. Waiting time increase from 1997 to 2000 appears to be due to increased demand for services without corresponding increases in resources. Less treatment delay for women older than 70 is due to more of these women being treated the same day they received their diagnosis.

Conclusion: Only 44% of women had a waiting time of 14 days or less as recommended by the CSSO. The number of women who will have to wait longer than recommended for treatment will likely increase without a significant increase in oncological resources. The basis for differences in waiting times as a function of age needs to be further investigated to ensure equitable access to care.

Reference

  • 1.Canadian Cancer Statistics 2002. Toronto: National Cancer Institute of Canada. 2002. [Google Scholar]
  • 2.Caplan LS, Helzlsouer K. Delay in breast cancer: A review of the literatur. Public Health Re. 1992;20:187–214. [PubMed] [Google Scholar]
  • 3.Canadian Society for Surgical Oncology position statement. Available on-line. 2003. [Google Scholar]
  • 4.O’Mahoney M. Women’s lived experience of breast biopsy: A phenomenological stud. J Clin Nur. 2001;10:512–20. doi: 10.1046/j.1365-2702.2001.00493.x. [DOI] [PubMed] [Google Scholar]
  • 5.Padgett DK, Yedidia M, Kerner J, Mandelblatt J. The emotional consequences of false positivy mammography: African-American women’s reactions in their own word. Women & Healt. 2001;33:1–14. doi: 10.1300/J013v33n03_01. [DOI] [PubMed] [Google Scholar]
  • 6.Olivotto IA, Bancej C, Goel V, Snider J, McAuley G, Irvine B, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian province. CMA. 2001;165:277–83. [PMC free article] [PubMed] [Google Scholar]
  • 7.Gaudine A, Sturge-Jacobs M, Kennedy M. The experience of waiting and life during breast cancer survivor. Res Theory Nurs Pract. 2003;17:153–68. doi: 10.1891/rtnp.17.2.153.53172. [DOI] [PubMed] [Google Scholar]
  • 8.Poole K, Lyne P. The ‘cues’ to diagnosis: Describing the monitoring activities of women undergoing diagnostic investigations for breast diseas. J Adv Nurt. 2000;31:200–8. doi: 10.1046/j.1365-2648.2000.01345.x. [DOI] [PubMed] [Google Scholar]
  • 9.Elwood MJ, Moorehead W. Delay in diagnosis and long-term survival in breast cances. BMA. 1980;280:1291–94. doi: 10.1136/bmj.280.6227.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Feldman JG, Saunders M, Carter A, Gardner B. The effects of patient delay and symptoms other than a lump on survival in breast cance. Cances. 1983;51:1226–29. doi: 10.1002/1097-0142(19830401)51:7<1226::AID-CNCR2820510709>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  • 11.Charlson ME. Delay in the treatment of carcinoma of the breas. Surgery,Gynecology and Obstetric. 1985;160:393–99. [PubMed] [Google Scholar]
  • 12.Vernon SW, Tilley B, Neale V, Steinfeldt L. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cance. Cances. 1985;55:1563–71. doi: 10.1002/1097-0142(19850401)55:7<1563::AID-CNCR2820550726>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  • 13.Hainsworth PJ, Henderson M, Bennett R. Delayed presentation in breast cancer: Relationship to tumour stage and survival. Breast. 1993;2:37–41. doi: 10.1016/0960-9776(93)90035-E. [DOI] [Google Scholar]
  • 14.Huguley CM, Brown R, Greenberg R, Clark S. Breast self-examination and survival from breast cance. Cances. 1988;62:1389–96. doi: 10.1002/1097-0142(19881001)62:7<1389::AID-CNCR2820620725>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  • 15.Rossi S, Cinini C, Pietro C, Lombardi C, Crucitti A, Bellantone R, Crucitti F. Diagnostic delay in breast cancer: Correlation with disease stage and prognosi. Tumour. 1990;76:559–62. doi: 10.1177/030089169007600609. [DOI] [PubMed] [Google Scholar]
  • 16.Rabinovich MG, Vallejo C, Perez J, Rodriguez R, Cuevas M, Machiavelli M, et al. Impact of delay to treatment upon survival in 1067 patients with breast cance. Int J Oncolog. 1993;2:197–201. [PubMed] [Google Scholar]
  • 17.Afzelius P, Zedeler K, Sommer H, Mourdsen H, Blichert-Toft M. Patient’s and doctor’s delay in primary breast cance. Acta Oncon. 1994;33:345–51. doi: 10.3109/02841869409098427. [DOI] [PubMed] [Google Scholar]
  • 18.Raabe NK, Fossaa S. Primary invasive breast carcinoma in Oslo 1980–198. Acta Oncol. 1996;35:9–15. doi: 10.3109/02841869609098473. [DOI] [PubMed] [Google Scholar]
  • 19.Richards MA, Wetscombe A, Love S, Littlejohns P, Ramirez A. Influence of delay on survival in patients with breast cancer: A systematic review. Lances. 1999;353:1119–26. doi: 10.1016/S0140-6736(99)02143-1. [DOI] [PubMed] [Google Scholar]
  • 20.Richards MA, Smith P, Ramirez A, Fentiman I, Rubens R. The influence on survival of delay in the presentation and treatment of symptomatic breast cance. Br J Cances. 1999;79:858–64. doi: 10.1038/sj.bjc.6690137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wyatt RM, Beddoe A, Dale R. The effects of delays in radiotherapy treatment on tumour contro. Phys Med Biol. 2003;48:139–55. doi: 10.1088/0031-9155/48/2/301. [DOI] [PubMed] [Google Scholar]
  • 22.Alderson MR, Hamlin I, Staunton M. The relative significance of prognostic factors in breast carcinom. Br J Cances. 1971;25:646–56. doi: 10.1038/bjc.1971.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cance. Cances. 1975;35:714–20. doi: 10.1002/1097-0142(197503)35:3<714::AID-CNCR2820350326>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  • 24.Wallgren A, Silfversward C, Eklund G. Prognostic factors in mammary carcinom. Acta Radio. 1976;15:1–15. doi: 10.3109/02841867609132703. [DOI] [PubMed] [Google Scholar]
  • 25.Fisher ER, Redmond C, Fisher B. A perspective concerning the relationship of duration of symptoms to treatment failure in patients with breast cance. Cances. 1977;40:3160–67. doi: 10.1002/1097-0142(197712)40:6<3160::AID-CNCR2820400661>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 26.Neave LM, Mason B, Kay R. Does delay in diagnosis of breast cancer affect survival. Breast Cancer Res Treat. 1990;15:103–8. doi: 10.1007/BF01810782. [DOI] [PubMed] [Google Scholar]
  • 27.Goodwin JS, Samet J, Hunt W. Determinants of survival in older cancer patient. J Natl Cancer Inst. 1996;88:1031–38. doi: 10.1093/jnci/88.15.1031. [DOI] [PubMed] [Google Scholar]
  • 28.Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lances. 1999;353:1132–35. doi: 10.1016/S0140-6736(99)02374-0. [DOI] [PubMed] [Google Scholar]
  • 29.Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioners’ referrals: Retrospective national survey. BM. 2000;230:838–39. doi: 10.1136/bmj.320.7238.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Robinson D, Bell C, Moller H, Basnett I. Effect of the UK government’s 2-week target on waiting times in women with breast cancer in southeast Englan. Br J Cances. 2003;89:492–96. doi: 10.1038/sj.bjc.6601149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Khawaja A, Allan S. Has the breast cancer ‘two week wait’ guarantee for assessment made any difference. Eur J Surg Oncology. 2000;26:536–39. doi: 10.1053/ejso.2000.0942. [DOI] [PubMed] [Google Scholar]
  • 32.Mackillop WJ, Fu H, Quirt C, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontari. Int J Radiat Oncol Biol Phy. 1994;30:221–28. doi: 10.1016/0360-3016(94)90538-X. [DOI] [PubMed] [Google Scholar]
  • 33.Mayo NE, Scott S, Shen N, Hanley J, Goldberg M, MacDonald N. Waiting time for breast cancer surgery in Quebec. CMA. 2001;164:1132–38. [PMC free article] [PubMed] [Google Scholar]
  • 34.Simunovic M, Gagliardi A, McCready D, Coates A, Levine M, DePetrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontari. CMA. 2001;165:421–25. [PMC free article] [PubMed] [Google Scholar]
  • 35.Caplan LS, May D, Richardson L. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991–1995. Am J Public Healt. 2000;90:130–34. doi: 10.2105/AJPH.90.1.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Burgess CC, Ramirez A, Richards M, Love S. Who and what influences delayed presentation in breast cance. Br J Cances. 1998;77:1343–48. doi: 10.1038/bjc.1998.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Caplan LS, Helzlsouer K, Shapiro S, Freedman L, Coates R, Edwards B. System delay in breast cancer in Whites and Black. Am J Epidemiol. 1995;142:804–12. doi: 10.1093/oxfordjournals.aje.a117719. [DOI] [PubMed] [Google Scholar]
  • 38.Finley ML, Francis A. Risk factors and physician delay in the diagnosis of breast cance. Prog Clin Biol Res. 1983;130:351–60. [PubMed] [Google Scholar]
  • 39.Nichols S, Waters W, Fraser M, Wheeler M, Ingham S. Delay in the presentation of breast symptoms for consultant investigatio. Comm Med. 1981;3:217–25. doi: 10.1007/BF02549119. [DOI] [PubMed] [Google Scholar]
  • 40.Adam SA, Horner J, Vessey M. Delay in treatment for breast cance. Comm Med. 1980;2:195–201. doi: 10.1007/BF02549023. [DOI] [PubMed] [Google Scholar]
  • 41.MacArthur C, Smith A. Delay in breast cancer and the nature of presenting symptom. Lances. 1981;1:601–3. doi: 10.1016/S0140-6736(81)92044-4. [DOI] [PubMed] [Google Scholar]
  • 42.Bywaters JL. The incidence and management of female breast disease in a general practic. J R Coll General Practitioner. 1977;27:353–57. [PMC free article] [PubMed] [Google Scholar]
  • 43.Greer S. Psychological aspects: Delay in the treatment of breast cance. Proceeding R Soc Med. 1974;67:470–72. [PMC free article] [PubMed] [Google Scholar]
  • 44.North American Association of Central Cancer Registries. Available on-line at http://www.naacr.org/.
  • 45.Alberta Cancer Registry: Annual Report of Cancer Statistics, 1997–99. Alberta Cancer Board. 2002. Available on-line at http://www.cancerboard.ab.ca/.cancer/cancer_online.html (accessed 2003 Aug 28).
  • 46.Health Canad. Canada Health Act Annual Report. Ottawa, ON: Author; 2001. [Google Scholar]
  • 47.College of Physicians and Surgeons of Albert. Physician Resource Statistic. Available on-line at http://www.cpsa.ab.ca/physicianregistration/.physician_statistics.asp.

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES